Latest News about EDIT
Recent news which mentions EDIT
Editas Medicine Tumbles 20% After CEO Steps Down
January 22, 2019
From Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
January 22, 2019
From Benzinga
From Benzinga
Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Profit Tops Expectations
January 22, 2019
From Benzinga
4 Gene-Editing Technologies That Could Replace CRISPR
January 18, 2019
From Motley Fool
The Best CRISPR Stock Gained 21% in 2018, While The Worst Lost 29%
January 10, 2019
From Motley Fool
4 Reasons Editas Medicine's Future Looks Really Bright
January 10, 2019
From Motley Fool
24 Stocks Moving In Friday's Pre-Market Session
December 28, 2018
From Benzinga
60 Biggest Movers From Friday
December 23, 2018
From Benzinga
Why Perrigo, New Age Beverages, and Editas Medicine Slumped Today
December 21, 2018
From Motley Fool
40 Stocks Moving In Friday's Mid-Day Session
December 21, 2018
From Benzinga
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
December 20, 2018
From Benzinga
Is Editas Medicine a Buy?
December 09, 2018
From Motley Fool
Better Buy: Editas Medicine vs. Sangamo Therapeutics
December 02, 2018
From Motley Fool
Why Crispr Therapeutics Stock Is Up 65% So Far in 2018
November 30, 2018
From Motley Fool
Why Crispr Therapeutics Stock Is Up By 65% So Far in 2018
November 30, 2018
From Motley Fool
Editas Medicine Makes Steady Progress in Another Solid Quarter
November 08, 2018
Tickers
EDIT
From Motley Fool
Editas Medicine, Inc. (EDIT) Q3 2018 Earnings Conference Call Transcript
November 07, 2018
Tickers
EDIT
From Motley Fool
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie
November 06, 2018
From Benzinga
Here's Why CRISPR Stocks Fell as Much as 40.7% in October
November 05, 2018
From Motley Fool
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
November 04, 2018
From Benzinga
Better Buy: Editas Medicine, Inc. vs. Intellia Therapeutics, Inc.
November 03, 2018
From Motley Fool
26 Stocks Moving In Thursday's Pre-Market Session
October 11, 2018
From Benzinga
Better Buy: Crispr Therapeutics AG vs. Editas
October 09, 2018
From Motley Fool
The Greatest Healthcare Stocks of the 21st Century -- and Some That Probably Will Be
September 26, 2018
From Motley Fool
Benzinga's Top Upgrades, Downgrades For September 21, 2018
September 21, 2018
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.